Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Test for Oxaliplatin Hypersensitivity Reaction
NCT07613905Not yet recruiting
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, open-label trial of oxaliplatin in Hypersensitivity reaction (2 arms), sponsored by Fujian Medical University Cancer Hospital. Primary endpoint: Sensitivity and Specificity of Oxaliplatin Skin Test. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
oxaliplatin
03
Conditions
Hypersensitivity reaction
Beyond the preview
Go deeper on NCT07613905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07613905.